When it comes to sizing up pharma’s corporate reputation, U.S. patient groups put GlaxoSmithKline’s ViiV Healthcare, Horizon Therapeutics and Pfizer on top. | When it comes to sizing up pharma’s corporate reputation, U.S. patient groups put GlaxoSmithKline’s ViiV Healthcare, Horizon Therapeutics and Pfizer on top.